AU7363691A - Methods for treating interleukin-1 mediated diseases - Google Patents

Methods for treating interleukin-1 mediated diseases

Info

Publication number: AU7363691A
Authority: AU; Australia
Prior art keywords: methods; mediated diseases; treating interleukin; interleukin; treating
Prior art date: 1990-04-02
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.): Granted

Application number

AU73636/91A

Other versions

AU649245B2 (en

Inventor

David F. Carmichael

Christopher G. Smith

Robert C. Thompson

Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)

Amgen Inc

Original Assignee

Amgen Inc

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1990-04-02

Filing date

1991-03-20

Publication date

1991-10-03

1991-03-20 Application filed by Amgen Inc filed Critical Amgen Inc

1991-10-03 Publication of AU7363691A publication Critical patent/AU7363691A/en

1994-05-19 Application granted granted Critical

1994-05-19 Publication of AU649245B2 publication Critical patent/AU649245B2/en

1999-09-02 Assigned to AMGEN, INC. reassignment AMGEN, INC. Request to Amend Deed and Register Assignors: SYNERGEN, INC.

2011-03-20 Anticipated expiration legal-status Critical

Status Expired legal-status Critical Current

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/19—Cytokines; Lymphokines; Interferons
- A61K38/20—Interleukins [IL]

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Epidemiology (AREA)
Chemical & Material Sciences (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Immunology (AREA)
Medicinal Chemistry (AREA)
Pharmacology & Pharmacy (AREA)
Zoology (AREA)
Gastroenterology & Hepatology (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Preparation Of Compounds By Using Micro-Organisms (AREA)
Peptides Or Proteins (AREA)
Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

AU73636/91A 1990-04-02 1991-03-20 Methods for treating interleukin-1 mediated diseases Expired AU649245B2 (en)

Applications Claiming Priority (6)

Application Number	Priority Date	Filing Date
US530553		1983-09-09
US50274590A	1990-04-02	1990-04-02
US502745		1990-04-02
US52421090A	1990-05-16	1990-05-16
US524210		1990-05-16
US53055390A	1990-05-29	1990-05-29

Publications (2)

Publication Number	Publication Date
AU7363691A true AU7363691A (en)	1991-10-03
AU649245B2 AU649245B2 (en)	1994-05-19

Family

ID=27414214

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
AU73636/91A Expired AU649245B2 (en)	1990-04-02	1991-03-20	Methods for treating interleukin-1 mediated diseases

Country Status (5)

Country	Link
JP (3)	JP2609485B2 (en)
KR (1)	KR920005691A (en)
AU (1)	AU649245B2 (en)
CA (1)	CA2039458A1 (en)
IL (1)	IL97641A0 (en)

Cited By (11)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
WO1997028828A1 (en) *	1996-02-09	1997-08-14	Amgen Boulder Inc.	Composition comprising interleukin-1 inhibitor and controlled release polymer
US5739282A (en) *	1994-10-13	1998-04-14	Applied Research Systems Ars Holding N.V.	Interleukin-1 antagonist
US5837495A (en) *	1994-10-13	1998-11-17	Applied Research Systems Ars Holding N.V.	DNA encoding interleukin-1 antagonist
AU736876B2 (en) *	1996-12-06	2001-08-02	Amgen, Inc.	Combination therapy using an IL-1 inhibitor for treating IL-1 mediated diseases
US6294170B1 (en)	1997-08-08	2001-09-25	Amgen Inc.	Composition and method for treating inflammatory diseases
EP2087908A1 (en)	2001-06-26	2009-08-12	Amgen, Inc.	Antibodies to opgl
EP2277543A1 (en)	2002-09-06	2011-01-26	Amgen, Inc	Therapeutic anti-IL-1R1 monoclonal antibody
WO2013170636A1 (en)	2012-05-18	2013-11-21	爱德迪安（北京）生物技术有限公司	Protein and protein conjugate for diabetes treatment, and applications thereof
EP2816060A1 (en)	2005-11-14	2014-12-24	Amgen Inc.	Rankl antibody-PTH/PTHRP chimeric molecules
WO2015191783A2 (en)	2014-06-10	2015-12-17	Abbvie Inc.	Biomarkers for inflammatory disease and methods of using same
WO2020035482A1 (en)	2018-08-13	2020-02-20	Iltoo Pharma	Combination of interleukin-2 with an interleukin 1 inhibitor, conjugates and therapeutic uses thereof

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US6552170B1 (en)	1990-04-06	2003-04-22	Amgen Inc.	PEGylation reagents and compounds formed therewith
AU2804192A (en) *	1991-10-31	1993-06-07	Victoria University Of Manchester, The	Treatment of neurological conditions by an interleukin-1 inhibiting compound
KR100308332B1 (en) *	1995-04-07	2002-09-17	데이진 가부시키가이샤	Protective agent for organ or tissue
US8106098B2 (en)	1999-08-09	2012-01-31	The General Hospital Corporation	Protein conjugates with a water-soluble biocompatible, biodegradable polymer
US20010053764A1 (en) *	2000-05-12	2001-12-20	Sims John E.	Interleukin-1 inhibitors in the treatment of diseases
KR100733025B1 (en) *	2006-05-24	2007-06-28	윤인석	Structure of safety cap

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
JPH02223597A (en) *	1988-10-24	1990-09-05	Otsuka Pharmaceut Co Ltd	Interleukin-1beta derivative
JP2863265B2 (en) *	1989-05-19	1999-03-03	ハダサメディカルオーガニゼーション	Interleukin 1 inhibitor

1991
- 1991-03-20 AU AU73636/91A patent/AU649245B2/en not_active Expired
- 1991-03-21 IL IL97641A patent/IL97641A0/en not_active IP Right Cessation
- 1991-03-28 CA CA002039458A patent/CA2039458A1/en not_active Abandoned
- 1991-04-01 JP JP3068640A patent/JP2609485B2/en not_active Expired - Lifetime
- 1991-04-02 KR KR1019910005277A patent/KR920005691A/en not_active Ceased
1996
- 1996-06-26 JP JP8166399A patent/JP2942196B2/en not_active Expired - Lifetime
1999
- 1999-01-18 JP JP11009712A patent/JPH11269089A/en active Pending

Cited By (17)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US5739282A (en) *	1994-10-13	1998-04-14	Applied Research Systems Ars Holding N.V.	Interleukin-1 antagonist
US5837495A (en) *	1994-10-13	1998-11-17	Applied Research Systems Ars Holding N.V.	DNA encoding interleukin-1 antagonist
AU724960C (en) *	1996-02-09	2002-08-15	Swedish Orphan Biovitrum Ab (Publ)	Composition comprising interleukin-1 inhibitor and controlled release polymer
AU724960B2 (en) *	1996-02-09	2000-10-05	Swedish Orphan Biovitrum Ab (Publ)	Composition comprising interleukin-1 inhibitor and controlled release polymer
WO1997028828A1 (en) *	1996-02-09	1997-08-14	Amgen Boulder Inc.	Composition comprising interleukin-1 inhibitor and controlled release polymer
CZ299025B6 (en) *	1996-02-09	2008-04-02	Amgen Inc.	Pharmaceutical composition and use thereof
AU736876B2 (en) *	1996-12-06	2001-08-02	Amgen, Inc.	Combination therapy using an IL-1 inhibitor for treating IL-1 mediated diseases
US6733753B2 (en) *	1997-02-10	2004-05-11	Amgen Inc.	Composition and method for treating inflammatory diseases
US6294170B1 (en)	1997-08-08	2001-09-25	Amgen Inc.	Composition and method for treating inflammatory diseases
EP2087908A1 (en)	2001-06-26	2009-08-12	Amgen, Inc.	Antibodies to opgl
EP3492100A1 (en)	2001-06-26	2019-06-05	Amgen Inc.	Antibodies to opgl
EP2277543A1 (en)	2002-09-06	2011-01-26	Amgen, Inc	Therapeutic anti-IL-1R1 monoclonal antibody
EP3020414A1 (en)	2002-09-06	2016-05-18	Amgen, Inc	Therapeutic anti-il-1r1 monoclonal antibody
EP2816060A1 (en)	2005-11-14	2014-12-24	Amgen Inc.	Rankl antibody-PTH/PTHRP chimeric molecules
WO2013170636A1 (en)	2012-05-18	2013-11-21	爱德迪安（北京）生物技术有限公司	Protein and protein conjugate for diabetes treatment, and applications thereof
WO2015191783A2 (en)	2014-06-10	2015-12-17	Abbvie Inc.	Biomarkers for inflammatory disease and methods of using same
WO2020035482A1 (en)	2018-08-13	2020-02-20	Iltoo Pharma	Combination of interleukin-2 with an interleukin 1 inhibitor, conjugates and therapeutic uses thereof

Also Published As

Publication number	Publication date
AU649245B2 (en)	1994-05-19
JPH05112462A (en)	1993-05-07
JPH11269089A (en)	1999-10-05
JPH09118632A (en)	1997-05-06
KR920005691A (en)	1992-04-03
IL97641A0 (en)	1992-06-21
CA2039458A1 (en)	1991-10-03
JP2609485B2 (en)	1997-05-14
JP2942196B2 (en)	1999-08-30

Publication	Publication Date	Title
AU616091B2 (en)	1991-10-17	Treatment process
AU624464B2 (en)	1992-06-11	Skin treatment method
AU7629594A (en)	1995-02-20	Imidazoles for treating cytokine mediated disease
AU2293888A (en)	1989-04-06	Dosage form for treating cardiovascular diseases
AU5045190A (en)	1990-08-13	Filter apparatus
AU7363691A (en)	1991-10-03	Methods for treating interleukin-1 mediated diseases
AU5521290A (en)	1990-11-29	Induction-based assistive listening system
AU4524889A (en)	1990-05-28	Method for the treatment of periodontal disease
AU5869990A (en)	1991-01-10	Means for surgical treatment
AU3604989A (en)	1990-08-16	Depilation apparatus
AU6596590A (en)	1991-05-16	Deoxyfluoronucleoside process
AU6061090A (en)	1991-03-11	Photocoagulation apparatus
AU7438691A (en)	1992-01-30	Nut harvesting apparatus
AU6386390A (en)	1991-04-11	Therapeutic necleosides
AU6798490A (en)	1991-06-27	Ocular treatment apparatus
AU8601791A (en)	1992-04-30	Dewaxing process
AU6735490A (en)	1991-05-16	Process for chlorofluoropropanes
AU7213291A (en)	1991-09-03	Straw treatment apparatus
AU7467891A (en)	1991-10-21	Process for imparting knowledge
AU613355B2 (en)	1991-08-01	Method for treating skin diseases
AU3605089A (en)	1990-08-16	Depilation apparatus
AU6215290A (en)	1991-03-14	Method for activating protein c
AU7294491A (en)	1991-09-19	Labdanes and process for their preparation
AU9021291A (en)	1992-06-25	Adjustable diaper
AU630316B2 (en)	1992-10-22	Epilation apparatus